Healthcare Equipment and Supplies
Company Overview of Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc., a medical device company, engages in the development and commercialization of particle-based therapy devices for the selective and precise particle-based thermal destruction of solid tumors. It develops AuroLase therapy, an investigational medical device that is used to ablate irregularly shaped tumors or inoperable solid tumors in refractory or recurrent head and neck cancer treatments. The company also develops and sells research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences, Inc. was founded in 2002 and is based in Houston, Texas.
8285 El Rio Street
Houston, TX 77054
Founded in 2002
Key Executives for Nanospectra Biosciences, Inc.
Similar Private Companies By Industry
|St. Jude Medical Puerto Rico, Inc.||United States|
|Mars Veterinary, Inc.||United States|
|Medical Technology Group, Inc.||United States|
|Medical Action Industries Inc.||United States|
|Total Resources International Inc.||United States|
Recent Private Companies Transactions
August 22, 2014
To contact Nanospectra Biosciences, Inc., please visit www.nanospectra.com. Company data is provided by Capital IQ. Please use this form to report any data issues.